Scientists Unveil Lipid Nanoparticle Surface Structures Poised to Enhance Vaccine and Drug Delivery
In a groundbreaking advancement poised to revolutionize the field of drug delivery and vaccine development, scientists at the University of Nottingham’s School of Pharmacy have unveiled a pioneering technique for analyzing the intricate architecture...
Global Observatory Gathers to Expand Debate on Human Genome Editing
This week a diverse group of researchers, bioethicists, publishers and theologians, are gathering in Cambridge, Massachusetts, to extend and expand the rolling debate about the merits of human heritable genome editing (HHGE). The international...
Blocking IL1RAP protein may offer new approach to treat atherosclerosis
Atherosclerosis is the buildup of fat and calcium in the walls of blood vessels and represents the most common cause of cardiovascular disease. Recent research from örebro University indicates that inhibiting a specific protein...
Rapid, Affordable Targeted Sequencing Diagnoses Cobalamin C Disease
In a groundbreaking leap toward precision medicine, researchers have unveiled a method that dramatically enhances the speed, affordability, and reliability of diagnosing cobalamin C (cblC) disease, a rare but devastating metabolic disorder. This advancement...
Scratch That? De Novo Antibody Design Enters the AI Drug Discovery Toolbox
“Life could not exist without proteins. That we can now predict protein structures and design our own proteins confers the greatest benefit to humankind.” —2024 Nobel Prize in Chemistry Announcement
“This is for sure going to...
Whole Genome Sequencing Enhances Cancer Origin Detection
In a breakthrough poised to revolutionize oncology diagnostics, a team of researchers led by Rebello, Posner, and Dong has demonstrated how whole genome sequencing (WGS) can dramatically enhance the diagnosis and treatment strategies for...
Prime Medicine Chops 25% of Workforce, Pivots Pipeline as CEO Quits
Keith Gottesdiener, MD, former president and CEO of Prime Medicine
Prime Medicine is eliminating 25% of its workforce—about 50 jobs—in a restructuring that includes the company pivoting its prime editing-based pipeline focus to liver disease...
New partnership aims to advance treatments for blood disorders and leukemia
A new frontier into advancing treatments for children and adults with bone marrow failure, leukemia and other blood disorders will be achieved under a new partnership between Murdoch Children's Research Institute (MCRI) and US...
High-Responsivity Quantum Dot Phototransistors Revolutionize NIR Detection
In a groundbreaking advancement poised to redefine near-infrared photodetection and image communication, researchers have unveiled a novel class of phototransistors based on high-responsivity colloidal quantum dots. This innovation leverages the unique optoelectronic properties of...
Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents
Illumina is suing Element Biosciences, with the sequencing giant accusing its smaller rival of infringing on five of its patents covering flow cell and imaging technologies used in automated genetic sequencing, and Element vowing...
